Notice: This company has been marked as potentially delisted and may not be actively trading. ContraVir Pharmaceuticals (CTRV) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends CTRV vs. UPC, HSTO, SCPS, EVLO, CMRA, ARDS, STAB, CALA, EFTR, and MTEMShould you be buying ContraVir Pharmaceuticals stock or one of its competitors? The main competitors of ContraVir Pharmaceuticals include Universe Pharmaceuticals (UPC), Histogen (HSTO), Scopus BioPharma (SCPS), Evelo Biosciences (EVLO), Comera Life Sciences (CMRA), Aridis Pharmaceuticals (ARDS), Statera Biopharma (STAB), Calithera Biosciences (CALA), eFFECTOR Therapeutics (EFTR), and Molecular Templates (MTEM). These companies are all part of the "medical" sector. ContraVir Pharmaceuticals vs. Universe Pharmaceuticals Histogen Scopus BioPharma Evelo Biosciences Comera Life Sciences Aridis Pharmaceuticals Statera Biopharma Calithera Biosciences eFFECTOR Therapeutics Molecular Templates ContraVir Pharmaceuticals (NASDAQ:CTRV) and Universe Pharmaceuticals (NYSE:UPC) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, media sentiment, institutional ownership, risk, community ranking and analyst recommendations. Which has more risk & volatility, CTRV or UPC? ContraVir Pharmaceuticals has a beta of 1.16, suggesting that its stock price is 16% more volatile than the S&P 500. Comparatively, Universe Pharmaceuticals has a beta of 1.55, suggesting that its stock price is 55% more volatile than the S&P 500. Does the media refer more to CTRV or UPC? In the previous week, Universe Pharmaceuticals had 1 more articles in the media than ContraVir Pharmaceuticals. MarketBeat recorded 1 mentions for Universe Pharmaceuticals and 0 mentions for ContraVir Pharmaceuticals. Universe Pharmaceuticals' average media sentiment score of 1.24 beat ContraVir Pharmaceuticals' score of 0.00 indicating that Universe Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment ContraVir Pharmaceuticals Neutral Universe Pharmaceuticals Positive Which has stronger earnings & valuation, CTRV or UPC? Universe Pharmaceuticals has higher revenue and earnings than ContraVir Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioContraVir PharmaceuticalsN/AN/A-$9.45MN/AN/AUniverse Pharmaceuticals$26.73M0.01-$6.16MN/AN/A Do institutionals and insiders have more ownership in CTRV or UPC? 1.1% of ContraVir Pharmaceuticals shares are held by institutional investors. Comparatively, 0.2% of Universe Pharmaceuticals shares are held by institutional investors. 1.6% of ContraVir Pharmaceuticals shares are held by insiders. Comparatively, 57.4% of Universe Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is CTRV or UPC more profitable? Universe Pharmaceuticals' return on equity of 0.00% beat ContraVir Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets ContraVir PharmaceuticalsN/A -4,810.77% -130.14% Universe Pharmaceuticals N/A N/A N/A Does the MarketBeat Community believe in CTRV or UPC? ContraVir Pharmaceuticals received 219 more outperform votes than Universe Pharmaceuticals when rated by MarketBeat users. CompanyUnderperformOutperformContraVir PharmaceuticalsOutperform Votes21974.49% Underperform Votes7525.51% Universe PharmaceuticalsN/AN/A SummaryUniverse Pharmaceuticals beats ContraVir Pharmaceuticals on 8 of the 10 factors compared between the two stocks. Remove Ads Get ContraVir Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CTRV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CTRV vs. The Competition Export to ExcelMetricContraVir PharmaceuticalsPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$67,000.00$6.93B$5.64B$8.08BDividend YieldN/A2.71%4.89%4.04%P/E RatioN/A6.1223.7319.00Price / SalesN/A226.08381.75120.61Price / CashN/A65.6738.0534.64Price / Book0.116.656.904.26Net Income-$9.45M$139.34M$3.18B$247.00M ContraVir Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CTRVContraVir PharmaceuticalsN/A$0.08+16.2%N/A-96.9%$67,000.00N/A0.0014High Trading VolumeUPCUniverse PharmaceuticalsN/A$0.13-1.5%N/A-99.5%$226,000.00$26.73M0.00220News CoverageGap UpHSTOHistogenN/A$0.03flatN/A-91.4%$128,000.00$19,000.00-0.0120SCPSScopus BioPharmaN/A$0.00flatN/A-88.0%$13,000.00N/A0.009EVLOEvelo BiosciencesN/A$0.00flatN/A-99.2%$9,000.00N/A0.00120CMRAComera Life SciencesN/A$0.00flatN/A-99.6%$6,000.00$1.00M0.002High Trading VolumeARDSAridis PharmaceuticalsN/AN/AN/A-99.9%$5,000.00$3.09M0.0030STABStatera BiopharmaN/A$0.00-66.7%N/A-83.3%$5,000.00N/A0.0020Gap DownCALACalithera BiosciencesN/A$0.00flatN/A-97.6%$3,000.00N/A0.0060EFTReFFECTOR Therapeutics0.9855 of 5 stars$0.00+200.0%$24.00+3,999,900.0%-100.0%$3,000.00$3.55M0.0010Gap UpMTEMMolecular Templates1.0185 of 5 stars$0.00flatN/A-100.0%$3,000.00$23.48M0.00260 Remove Ads Related Companies and Tools Related Companies Universe Pharmaceuticals Competitors Histogen Competitors Scopus BioPharma Competitors Evelo Biosciences Competitors Comera Life Sciences Competitors Aridis Pharmaceuticals Competitors Statera Biopharma Competitors Calithera Biosciences Competitors eFFECTOR Therapeutics Competitors Molecular Templates Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CTRV) was last updated on 3/12/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'Trump Orders ‘National Digital Asset Stockpile’ THIS could be the coin they choose…Crypto 101 Media | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredWarning: What they're not telling you about these recent selloffsIn light of massive recent selloffs... our senior analyst Dan Ferris has issued a new warning for the American...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ContraVir Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share ContraVir Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CTRV Stock Alerts